Catalyst OrthoScience has received clearance from the U.S. Food & Drug Administration to market its reverse shoulder system. Catalyst expects to begin a limited user release in the United States in the second quarter of 2021 followed by a commercial launch later in 2021.
Read More
® indicates U.S. trademark registration. All trademarks and/or images are the property of their respective owners or holders.
© 2024 Catalyst OrthoScience Inc. All rights reserved.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.